Items Tagged ‘Lung Cancer’

February 3, 2022

Lung cancer: It is about more than smoking

By Susan Murphy Susan Murphy (@susanmurphy)

By Sharon Theimer World Cancer Day is February 4 and that makes this the ideal time to talk about lung cancer and smoking. Internationally, lung cancer is the most common cause of cancer deaths and the World Health Organization estimates that 90% of cases could be prevented by eliminating tobacco use. People who smoke are at the greatest risk. Smokeless tobacco is also associated […]

View full entry

Tags: #Dr. Aaron Mansfield, #mesothelioma, Lung Cancer


May 29, 2019

Individualizing Medicine 2019 Conference – practical precision cancer care approaches for your patients

By Sharon Rosen Sharon Rosen (@sharonhrosen)

Amidst the demands of providing care for patients with cancer, it can be challenging for oncologists and their care teams to keep up with the rapidly evolving field of genomics. Practical ways to apply the latest precision medicine discoveries is the focus of this year’s Individualizing Medicine Conference: Precision Cancer Care through Immunotherapy and Genomics, […]

View full entry

Tags: #CAR T-cell therapy, #CIMCon19, biliary cancer, breast cancer, center for individualized medicine, Dr. Alan Bryce, familial cancer syndromes, hematologic cancers, immunotherapies, Individualizing Medicine Conference 2019, Lung Cancer, lymphoma


August 2, 2017

Expanding the search: genetic testing reveals new targets, treatment options for cancer patients

By Sharon Rosen Sharon Rosen (@sharonhrosen)

Researchers in Mayo Clinic Center for Individualized Medicine are using new genetic tests developed at Mayo Clinic to find more effective therapies for cancer patients who have not benefited from standard treatment and are running out of options. The new tests look at a broader range of genetic characteristics than many standard tests. As a […]

View full entry

Tags: #3-d models, #boimarker, #CIMCon17, #DNA analysis, #Dr. Aaron Mansfield, #Dr. George Vasmatizis, #genetic variations, #liquid biopsies, center for individualized medicine, Genetic Testing, genomics, Lung Cancer


December 9, 2014

Tracing the Lineage of Lung Cancer Tumors

By Center for Individualized Medicine Center for Individualized Medicine (@samuelsmith5209)

    A diagnostic test based on chromosomal rearrangements can trace the lineage of lung cancer to determine whether two separate lung cancers in the same patient are independent tumors or a tumor that has spread to another region of the lung, a Mayo Clinic study has found. For patients with multiple tumors, that distinction […]

View full entry

Tags: biomarkers, cancer, center for individualized medicine, DNA, DNA Sequencing, dna test, DNA Testing, gene sequencing, genetic, Genetics, genome, genome science


June 24, 2014

Effective Methods for Combating Aggressive Forms of Lung Cancer Publication

By AJ Montpetit AJ Montpetit (@ajmontpetit)

  According to a recently published article in the journal Cancer Research, a new study from the Center for Individualized Medicine has found tumor sequencing of several different lung cancers and their surrounding tissue complicates the prevailing theory of linear lung cancer progression and offers new insights for management of this deadly cancer. Sequencing results […]

View full entry

Tags: cancer, center for individualized medicine, DNA, DNA Sequencing, dna test, DNA Testing, gene sequencing, Genetics, genome, genome science, Genome Sequencing, genomic medicine


December 19, 2013

Announcing Oncospire Genomics

By Mystery User

With lung cancer accounting for more cancer-related deaths each year than the next four leading cancer types combined, the need for earlier diagnosis and better treatment options is clear. Oncospire Genomics, the recently formed joint venture between Cancer Genetics, Inc and Mayo Clinic, aims to shift the tide in lung cancer treatment. The goal of […]

View full entry

Tags: Biobank, cancer, Cancer Genetics Inc, center for individualized medicine, Follicular lymphoma, Genetics, genomics, Gianrico Farrugia, Lung Cancer, mayo clinic, Multiple Myeloma, next generation sequencing


November 21, 2013

ASCL1 And RET Expression Defines Clinically Relevant Subgroup Of Lung Adenocarcinoma

By Center for Individualized Medicine Center for Individualized Medicine (@samuelsmith5209)

A recent publication, featuring the Director of the Biomarker Discovery Program at the Center for Individualized Medicine at Mayo Clinic, George Vasmatzis, examining the role of ASCL1 in the neuroendocrine differentiation of lung adenocarcinoma. The clinical significance of neuroendocrine differentiation in lung adenocarcinoma, and the most appropriate biomarkers for this assessment, has long been debated. In the […]

View full entry

Tags: ASCL1, biomarker, Biomarker Discovery, Biomarker Discovery Program, cancer, center for individualized medicine, chromogranin, DNA, George Vasmatzis, immunohistochemical, individualized medicine, Lung Cancer


October 17, 2013

Discovering Smoker’s Lung Cancer Biomarker

By AJ Montpetit AJ Montpetit (@ajmontpetit)

Researchers at Mayo Clinic recently found that a specific pair of proteins may be a successful prognostic biomarker for identifying smoking-related lung cancers. The clinical significance of neuroendocrine (NE) differentiation in lung adenocarcinoma (AD), and the most appropriate biomarkers for this assessment, has long been debated. In the absence of a gold standard, investigators have most […]

View full entry

Tags: biomarker, biomarkers, cancer, center for individualized medicine, George Vasmatzis, Lung Cancer, Personal Care, Personal Medicine, personalized care, personalized medicine, Smoke, Smoker


Contact Us · Privacy Policy